Condition
Monogenic Diabetes clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Monogenic Diabetes clinical trials that are recruiting, at sites in 4 countries (most in China (2), Hong Kong (1), Canada (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Monogenic Diabetes clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Chinese monogenic diabetes registry | — | Tianjin | Recruiting | Mar 25, 2026 |
| Dorzagliatin for glucokinase (GCK-MODY) diabetes | Phase 2 | Hong Kong | Recruiting | May 16, 2025 |
| Personalized management for monogenic diabetes using genetic screening | — | Tianjin | Recruiting | Dec 24, 2024 |
| Understanding beta cell disorders through genetic insights | — | Exeter, Devon | Recruiting | Jun 27, 2024 |
| Identifying Monogenic Diabetes Misdiagnosed as Type 1 | — | Montreal, Quebec | Recruiting | Jun 17, 2019 |
All recruiting trials (5)
-
Chinese monogenic diabetes registry
This project will test whether an online and mobile registry can find and genetically confirm people in China with monogenic forms of diabetes, including neonatal diabetes and MODY.
-
Dorzagliatin for glucokinase (GCK-MODY) diabetes
This trial will test whether dorzagliatin, a drug that activates glucokinase, can lower blood sugar in adults with GCK-MODY caused by an inactivating GCK mutation.
-
Personalized management for monogenic diabetes using genetic screening
This study is testing a new online platform that helps people with monogenic diabetes by using genetic screening to create personalized treatment plans for better blood sugar control.
-
Understanding beta cell disorders through genetic insights
This study is trying to learn more about beta cell problems, like diabetes, by looking at the genes of people with and without these issues to see if it can help find new treatments.
-
Identifying Monogenic Diabetes Misdiagnosed as Type 1
This study is trying to find out how often young people are wrongly diagnosed with type 1 diabetes when they actually have a rare form called monogenic diabetes, by testing their blood and looking for specific genetic changes.
Related topics
Quick answers
How many Monogenic Diabetes clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Hong Kong (1 trial), Canada (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.